T2 Biosystems, Inc. (TTOO)
0.001
0.00 (0.00%)
USD |
OTCM |
Sep 15, 16:00
T2 Biosystems Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.71M |
| June 30, 2024 | -5.898M |
| March 31, 2024 | -37.77M |
| December 31, 2023 | -28.04M |
| September 30, 2023 | -19.24M |
| June 30, 2023 | -36.42M |
| March 31, 2023 | -49.89M |
| December 31, 2022 | -39.66M |
| September 30, 2022 | -31.34M |
| June 30, 2022 | -37.52M |
| March 31, 2022 | -25.65M |
| December 31, 2021 | -12.90M |
| September 30, 2021 | -2.463M |
| June 30, 2021 | 9.009M |
| March 31, 2021 | -0.566M |
| December 31, 2020 | 8.726M |
| September 30, 2020 | 17.57M |
| June 30, 2020 | -4.388M |
| March 31, 2020 | -7.697M |
| December 31, 2019 | -34.00M |
| September 30, 2019 | -25.91M |
| June 30, 2019 | -15.62M |
| Date | Value |
|---|---|
| March 31, 2019 | -1.58M |
| December 31, 2018 | 11.39M |
| September 30, 2018 | 23.76M |
| June 30, 2018 | 31.98M |
| March 31, 2018 | -10.09M |
| December 31, 2017 | 1.34M |
| September 30, 2017 | 18.13M |
| June 30, 2017 | 12.32M |
| March 31, 2017 | 26.03M |
| December 31, 2016 | 39.34M |
| September 30, 2016 | 50.58M |
| June 30, 2016 | 22.66M |
| March 31, 2016 | 35.09M |
| December 31, 2015 | 46.94M |
| September 30, 2015 | 23.81M |
| June 30, 2015 | 34.05M |
| March 31, 2015 | 43.48M |
| December 31, 2014 | 53.00M |
| September 30, 2014 | 61.43M |
| June 30, 2014 | 9.646M |
| March 31, 2014 | 16.59M |
| December 31, 2013 | 23.27M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| STRATA Skin Sciences, Inc. | 2.908M |
| Omnia Wellness, Inc. | -- |
| ABVC BioPharma, Inc. | 10.29M |
| Anika Therapeutics, Inc. | 137.28M |
| Perspective Therapeutics, Inc. | 323.86M |